SeaStar Medical Holding (ICU) Total Debt (2020 - 2024)
SeaStar Medical Holding's (ICU) quarterly Total Debt came in at $3.7 million in Q1 2024, down 54.52% YoY from $8.1 million in Q2 2023, and down 55.54% on a QoQ basis from $8.3 million in Q4 2023.
SeaStar Medical Holding (ICU) Total Debt (2020 - 2024) Analysis & Trends
SeaStar Medical Holding (ICU) has 4 years of Total Debt data on file, last reported at $3.7 million in Q1 2024.
- Quarterly Total Debt fell 54.52% year-over-year to $3.7 million in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $3.7 million (down 54.52% YoY) and the FY2023 annual result came in at $8.3 million, up 8.76% from the prior year.
- Total Debt retreated to $3.7 million in Q1 2024, from $8.3 million in the prior quarter.
- In the past five years, Total Debt ranged from a high of $10.1 million in Q3 2023 to a low of $126413.0 in Q4 2020.
- A 4-year average of $4.4 million and a median of $3.2 million in 2022 frame the typical range for Total Debt.
- Annual changes were most pronounced in 2023 — Total Debt jumped 2524.19% — and 2024, when it slumped 54.52%.
- Tracing ICU's Total Debt over 4 years: stood at $126413.0 in 2020, then surged by 5953.17% to $7.7 million in 2022, then rose by 8.76% to $8.3 million in 2023, then sank by 55.54% to $3.7 million in 2024.
- The last three Total Debt figures came in at $3.7 million (Q1 2024), $8.3 million (Q4 2023), and $10.1 million (Q3 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 770.36 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 9.34 Bn |
| 10 | SeaStar Medical Holding | 13.68 Mn | 6.68 Mn | 561,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 3.70 Mn |
| Dec 31, 2023 | 8.32 Mn |
| Sep 30, 2023 | 10.13 Mn |
| Jun 30, 2023 | 2.23 Mn |
| Mar 31, 2023 | 8.14 Mn |
| Dec 31, 2022 | 7.65 Mn |
| Sep 30, 2022 | 2.77 Mn |
| Jun 30, 2022 | 911,940.00 |
| Mar 31, 2022 | 310,000.00 |
| Dec 31, 2020 | 126,413.00 |